Barclays PLC lowered its position in shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report) by 93.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,421 shares of the company’s stock after selling 145,472 shares during the period. Barclays PLC’s holdings in iShares U.S. Medical Devices ETF were worth $557,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Assetmark Inc. grew its stake in shares of iShares U.S. Medical Devices ETF by 20.7% during the third quarter. Assetmark Inc. now owns 1,615 shares of the company’s stock valued at $96,000 after buying an additional 277 shares during the last quarter. Raymond James & Associates grew its position in iShares U.S. Medical Devices ETF by 0.5% during the 3rd quarter. Raymond James & Associates now owns 378,727 shares of the company’s stock worth $22,428,000 after acquiring an additional 1,756 shares during the last quarter. International Assets Investment Management LLC grew its position in iShares U.S. Medical Devices ETF by 5,167.0% during the 3rd quarter. International Assets Investment Management LLC now owns 758,814 shares of the company’s stock worth $44,937,000 after acquiring an additional 744,407 shares during the last quarter. Private Advisor Group LLC increased its stake in iShares U.S. Medical Devices ETF by 10.0% in the 3rd quarter. Private Advisor Group LLC now owns 66,263 shares of the company’s stock worth $3,924,000 after purchasing an additional 6,022 shares during the period. Finally, Blue Trust Inc. lifted its position in iShares U.S. Medical Devices ETF by 186.3% in the third quarter. Blue Trust Inc. now owns 1,062 shares of the company’s stock valued at $60,000 after purchasing an additional 691 shares during the last quarter.
iShares U.S. Medical Devices ETF Stock Performance
Shares of iShares U.S. Medical Devices ETF stock opened at $58.32 on Friday. iShares U.S. Medical Devices ETF has a 52-week low of $52.60 and a 52-week high of $61.28. The company’s 50 day moving average price is $59.66 and its 200-day moving average price is $58.12. The stock has a market capitalization of $5.51 billion, a price-to-earnings ratio of 35.18 and a beta of 0.83.
iShares U.S. Medical Devices ETF Profile
The iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select \u002F Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is managed by BlackRock.
Featured Stories
- Five stocks we like better than iShares U.S. Medical Devices ETF
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Legacy Tech Companies Reemerging as AI Leaders
- What is MarketRank™? How to Use it
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What is the S&P 500 and How It is Distinct from Other Indexes
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Want to see what other hedge funds are holding IHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report).
Receive News & Ratings for iShares U.S. Medical Devices ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Medical Devices ETF and related companies with MarketBeat.com's FREE daily email newsletter.